CORONA Remedies Limited

NSE: CORONA

₹1,721.1

-0.77%EOD · 11 Jun

Market Cap

—

52W Range

₹1949 / ₹1337

Volume

1Y Return

—

P/E Ratio

57.1

P/B Ratio

14.1

ROE

27.4%

Debt / Equity

22.07

Technical Indicators

125d data — partial · objective math, not advice

Returns

-0.8%

-0.2%

-5.4%

+5.5%

—

RSI (14)

57 Neutral

Moving Averages (price vs MA)

20-DMA

₹1705

above

50-DMA

₹1664

above

150-DMA

—

200-DMA

—

From 52W High

-11.7%

From 52W Low

+28.8%

Support (20D)

₹1656

Resistance (20D)

₹1830

Technical indicators are objective calculations from historical EOD prices (RSI, moving averages, Weinstein stage, Minervini trend-template, relative strength). For educational reference only — not a buy/sell recommendation.

News & FilingsGoogle News + BSE

Stocks to Watch Today: Sammaan Capital, Granules, IndiGo, Corona Remedies, Jubilant Ingrevia, Pace...
Moneycontrol.com· 1 Apr
Corona Remedies listing today: Stock makes stellar entry on Dalal Street; lists at 38% premium over issue
The Times of India· 15 Dec
Corona Remedies share price: Stock debuts at over 38% premium on NSE; here's how much investors made
Upstox· 15 Dec
2008 global crash to 2020 COVID: How Nifty 50 plunged up to 59% in crises but rebounded
The Economic Times· 16 Mar
Corona Remedies share price makes dream debut, lists at ₹1,461 on NSE — up 37.57% over IPO price
Mint· 15 Dec
New NSE report shows Gujarat investor trends shifting: Covid-era entrants struggle as defence, solar & engi...
Bhaskar English· 16 Nov

News via Google News · Not verified by IPOpulse · Not investment advice

Community discussion(0)

No comments yet — be the first to share your view.